Tag: NASDAQ:ALLO

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Year to date metric has recorded a gain of 9.35%.However, over the last six months, we can see a weaker performance of 8.33%. Over the last 30 days, the price of ALLO has leaped by -16.33%. And in the last five days, it has fallen by -13.76%. The market performance of Allogene Therapeutics Inc has been somewhat unstable. Over the past year, the company’s stock achieved a high of $6.89 on 05/15/23, with the

The stock market performance of Allogene Therapeutics Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $6.89 on 05/15/23, while the lowest price during the same time frame was $2.23, recorded on 12/01/23. 52-week price history of ALLO Stock Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Allogene Therapeutics Inc’s current trading price is -42.09% away from its 52-week high, while its distance from the 52-week low is 78.92%. The stock’s price range for this

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Allogene Therapeutics Inc’s current trading price is -39.11% away from its 52-week high, while its distance from the 52-week low is 88.12%. The stock’s price range during this period has varied between $2.23 and $6.89. The company, active in the Healthcare sector, saw a trading volume of around 3.03 million for the day, considerably higher average daily volume of 2.94 million observed over the last three months. Allogene Therapeutics Inc had a pretty Dodgy run

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Allogene Therapeutics Inc’s current trading price is -20.75% away from its 52-week high, while its distance from the 52-week low is 144.84%. The stock’s price range during this period has varied between $2.23 and $6.89. The company, active in the Healthcare sector, saw a trading volume of around 2.87 million for the day, considerably lower average daily volume of 3.05 million observed over the last three months. Allogene Therapeutics Inc’s stock has had a tumultuous